Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harikrishnareddy Paluvai

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Oncology|October 14, 2018
Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformationHarikrishnareddy Paluvai, Eros Di Giorgio, Claudio Brancolini
Cells|February 23, 2020
The Histone Code of SenescenceHarikrishnareddy Paluvai, Eros Di Giorgio, Claudio Brancolini
Frontiers in Molecular Biosciences|September 7, 2023
Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseasesHarikrishnareddy Paluvai, Kumar D Shanmukha, Jens Tyedmers, et al.
International Journal of Molecular Sciences|December 18, 2019
Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro ModelsEros Di Giorgio, Harikrishnareddy Paluvai, Raffaella Picco, et al.
Progress in Molecular Biology and Translational Science|May 24, 2023
Histone deacetylase (HDACs) inhibitors: Clinical applicationsKumar D Shanmukha, Harikrishnareddy Paluvai, Santosh K Lomada, et al.
Nucleic Acids Research|June 14, 2024
HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repairEros Di Giorgio, Emiliano Dalla, Vanessa Tolotto, et al.
Nucleic Acids Research|November 23, 2019
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cellsEros Di Giorgio, Emiliano Dalla, Elisa Franforte, et al.
Genome Biology|May 10, 2021
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancersEros Di Giorgio, Harikrishnareddy Paluvai, Emiliano Dalla, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Oncology|October 14, 2018
Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformationHarikrishnareddy Paluvai, Eros Di Giorgio, Claudio Brancolini
Cells|February 23, 2020
The Histone Code of SenescenceHarikrishnareddy Paluvai, Eros Di Giorgio, Claudio Brancolini
Frontiers in Molecular Biosciences|September 7, 2023
Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseasesHarikrishnareddy Paluvai, Kumar D Shanmukha, Jens Tyedmers, et al.
International Journal of Molecular Sciences|December 18, 2019
Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro ModelsEros Di Giorgio, Harikrishnareddy Paluvai, Raffaella Picco, et al.
Progress in Molecular Biology and Translational Science|May 24, 2023
Histone deacetylase (HDACs) inhibitors: Clinical applicationsKumar D Shanmukha, Harikrishnareddy Paluvai, Santosh K Lomada, et al.
Nucleic Acids Research|June 14, 2024
HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repairEros Di Giorgio, Emiliano Dalla, Vanessa Tolotto, et al.
Nucleic Acids Research|November 23, 2019
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cellsEros Di Giorgio, Emiliano Dalla, Elisa Franforte, et al.
Genome Biology|May 10, 2021
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancersEros Di Giorgio, Harikrishnareddy Paluvai, Emiliano Dalla, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Pageof 1